University of New Mexi
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of New Mexi sits in the top decile of US sponsors by registered trial count (#286 of 15,742 sponsors by registered trial count).
University of New Mexi: 76 sponsored US clinical trials, 23 recruiting.
University of New Mexi sponsors 76 registered US clinical trials on ClinicalTrials.gov, 23 of them currently recruiting, and 42 completed. 3 of these trials are in Phase 3-4 (later-stage) and 14 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Chronic Pain, with 6 trials.
Top-decile sponsor footprint
University of New Mexi ranks in the top decile of sponsors by registered trial count (#286 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
42 of 42 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (100.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
76 total, page 1 of 2
PREPARE: Perioperative REhabilitation Around Vaginal Prolapse RepAir Surgery for Recovery Enhancement
NCT07265973
Opioid Adherence and Support Through Innovative Texting Strategies
NCT07350148
Wellness, Alcohol, Vitals, and Emotions
NCT06982443
Magnetic Resonance Analysis of Neural Inflammatory Factors and External Stimulation
NCT06940609
Effect of Tirzepatide on Markers of MASLD in Patients With Obesity
NCT06934642
Cervical Ripening Balloons for Same-Day Cervical Prep
NCT06964373
WEAVE NM: Heart Health and Nutrition for Life
NCT07074145
Dual Diagnosis Training Trial
NCT06238258
Multimodal Image Analysis and Guidance of Neuromodulation for Trauma-Related Symptoms
NCT06449326
MDMA for Co-occurring PTSD and OUD After Childbirth
NCT05219175
Particulate vs. Non-Particulate Steroid for Sacroiliac Joint Injection
NCT06268704
Effects of Multiple-Session Transcranial Direct Current Stimulation (tDCS) on Behavioral, Physiological, and Electrophysiological Measures With Adults With Autism Spectrum Disorder (ASD)
NCT06495684
Cognitive Strategies for Optimizing Brain Health And Managing Transgenerational Vascular Risk Factors Post-Stroke
NCT06479174
Amplitude Titration to Improve ECT Clinical Outcomes
NCT05699226
Ketogenic Diet and Diabetes Demonstration Project
NCT06115265
Opioid and Pain Treatment in Indigenous Communities (OPTIC) Trial
NCT06565416
Targeted TDCS to Enhance Speech-Language Treatment Outcome in Persons With Chronic Post-Stroke Aphasia.
NCT04432883
Motivational Interviewing at Intake vs Intake as Usual on Client Engagement in Addiction Treatment
NCT05489068
Control Network Neuromodulation to Enhance Cognitive Training in Complex Traumatic Brain Injury
NCT05236010
De-identified UNMH EEG Corpus Database Creation With Fully De-identified Clinical Information
NCT05140265
Exercise Enhances Wound Healing in Patients With Diabetic Foot Ulcers
NCT04791449
American Indian Chronic Renal Insufficiency Cohort Study (AI-CRIC Study)
NCT04185844
Thinking Zinc: a Study of Zinc Supplements on the Navajo Nation
NCT03908736
Resistance Training for the Improvement of Glycemic Control in Prediabetes
NCT06697756
Individualized Targeting and Neuromodulation of Late-Life Depression
NCT04543773
Effort During Resistance Training in Type 2 Diabetes
NCT06497842
Is the Degree of Perceived Effort During Resistance Exercise Important for Improvements in Blood Glucose
NCT06208189
TeleHealth Resources for IndiVidualizEd Goals (THRIVE) in Alcohol Recovery Study
NCT06074341
Healing Opioid Misuse and Pain Through Engagement (HOPE) Trial
NCT05571917
Access to Kidney Transplantation in Minority Populations
NCT04615819
Intervention to Address Disparate Mental Health Consequences of COVID-19 Pandemic on Latinx and African Newcomers
NCT05092542
Pain and Opioids: Integrated Treatment In Veterans
NCT04648228
Comprehensive Process Model of AA-related Behavior Change
NCT04618653
Catholic Health Initiatives (CHI) St. Joseph's Children Home Visiting Longitudinal Study
NCT05729945
Belongingness in Nursing Through Mindfulness - BEING Mindful: A Pilot Study
NCT06866288
Ibuprofen and Biomarkers of Acute Kidney Injury After Running in the Heat
NCT06247462
Serum Biomarkers to Predict Response to Angiotensin II in Septic Shock
NCT05824767
Standing Strong in Tribal Communities: Assessing Elder Falls Disparity
NCT04876729
Use of NIRS in Preterm Population Born at Altitude
NCT04639583
Ixekizumab in Adult Patients With Lichen Planus and Lichen Planopilaris
NCT05030415
Mindfulness and Yoga for Pain With Interstitial Cystitis Evaluation
NCT04820855
A Brief Parental Intervention on Learning and Education in Childhood Cancer
NCT05268315
Efficacy and Mechanisms of Mobile-Delivered Alcohol Attentional Bias Modification
NCT04263259
Expectations and Pain Control Advancement In surgeRy: The REPAIR Trial
NCT03726476
Alcohol Misuse Intervention in Active Duty US Navy Personnel
NCT04893044
Non-Opioid Pramipexole and Pain
NCT03842709
Designing a Mental Health Model for Latina Women
NCT03901430
The Influence of Testosterone on Experimental Pain Perception
NCT05781685
Metaplasticity Experimental Design and Comparison of Motor Outcome Measure Sensitivity to Change
NCT03304262
Patient-Centered Versus Physician-Centered Counseling MidUrethral Sling Videos
NCT03198481
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 9 |
| Phase 2 | 5 |
| Phase 4 | 3 |
Therapeutic Areas
What is open in the University of New Mexi pipeline
23 recruiting of 76 indexed (30% open); 42 completed (55%).
Phase mix: 3 late (III/IV) vs 14 early (I/II) (early-phase heavy).
Top condition: Chronic Pain (6 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of New Mexi: open-pipeline peers nationwide
Peers matched on 76 registered trials and 30% open enrollment, not the therapeutic-area sidebar.
University of New Mexi sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 76 trials (± recruiting share)
- Ionis Pharmaceuticals · 76 trials · 12% recruiting
- MetroHealth Medical Center · 76 trials · 13% recruiting
- Texas Tech University Health Sciences Center · 76 trials · 13% recruiting
- University of Hawaii · 77 trials · 17% recruiting
Sponsors near 30% open enrollment (± trial volume)
- Tulane University · 30% recruiting · 73 trials
- New York University · 30% recruiting · 83 trials
- Adverum Biotechnologies · 30% recruiting · 10 trials
- Centre hospitalier de l'Université de Montréal (CHUM) · 30% recruiting · 10 trials
Related
What to do with this University of New Mexi page
76 registered trials is a research-attention snapshot, not an endorsement of University of New Mexi or any single study.
- 23 of University of New Mexi's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Chronic Pain is the condition University of New Mexi studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Chronic Pain trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
University of New Mexi pipeline card: 76 registered trials from official public datasets.Report a data error.